[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2017 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 6.23%
YoY- 62.3%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 514,500 533,036 467,987 474,312 480,710 483,976 312,940 39.42%
PBT 52,340 53,020 51,796 51,961 49,528 44,704 31,479 40.47%
Tax -10,368 -10,432 -9,696 -11,518 -11,118 -10,232 -4,653 70.84%
NP 41,972 42,588 42,100 40,442 38,410 34,472 26,826 34.88%
-
NP to SH 41,972 43,128 42,492 40,829 38,434 34,472 27,115 33.92%
-
Tax Rate 19.81% 19.68% 18.72% 22.17% 22.45% 22.89% 14.78% -
Total Cost 472,528 490,448 425,887 433,869 442,300 449,504 286,114 39.84%
-
Net Worth 209,983 206,429 479,809 474,230 463,071 463,071 454,703 -40.33%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 8,399 - 23,711 - 13,947 - 18,132 -40.21%
Div Payout % 20.01% - 55.80% - 36.29% - 66.87% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 209,983 206,429 479,809 474,230 463,071 463,071 454,703 -40.33%
NOSH 650,902 278,959 278,959 278,959 278,959 278,959 278,959 76.19%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 8.16% 7.99% 9.00% 8.53% 7.99% 7.12% 8.57% -
ROE 19.99% 20.89% 8.86% 8.61% 8.30% 7.44% 5.96% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 183.76 191.08 167.76 170.03 172.32 173.49 112.18 39.08%
EPS 6.44 15.28 15.09 14.49 13.76 13.72 9.62 -23.53%
DPS 3.00 0.00 8.50 0.00 5.00 0.00 6.50 -40.36%
NAPS 0.75 0.74 1.72 1.70 1.66 1.66 1.63 -40.48%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 53.45 55.37 48.61 49.27 49.94 50.28 32.51 39.42%
EPS 4.36 4.48 4.41 4.24 3.99 3.58 2.82 33.81%
DPS 0.87 0.00 2.46 0.00 1.45 0.00 1.88 -40.25%
NAPS 0.2181 0.2144 0.4984 0.4926 0.481 0.481 0.4723 -40.34%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 1.30 2.80 2.53 2.20 2.25 2.31 1.98 -
P/RPS 0.71 1.47 1.51 1.29 1.31 1.33 1.76 -45.49%
P/EPS 8.67 18.11 16.61 15.03 16.33 18.69 20.37 -43.50%
EY 11.53 5.52 6.02 6.65 6.12 5.35 4.91 76.94%
DY 2.31 0.00 3.36 0.00 2.22 0.00 3.28 -20.89%
P/NAPS 1.73 3.78 1.47 1.29 1.36 1.39 1.21 26.99%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 -
Price 1.08 3.35 2.97 2.20 2.03 2.32 2.23 -
P/RPS 0.59 1.75 1.77 1.29 1.18 1.34 1.99 -55.63%
P/EPS 7.20 21.67 19.50 15.03 14.73 18.77 22.94 -53.91%
EY 13.88 4.62 5.13 6.65 6.79 5.33 4.36 116.86%
DY 2.78 0.00 2.86 0.00 2.46 0.00 2.91 -3.00%
P/NAPS 1.44 4.53 1.73 1.29 1.22 1.40 1.37 3.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment